908 Devices Stock (NASDAQ:MASS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$7.11

52W Range

$5.03 - $9.34

50D Avg

$8.05

200D Avg

$7.01

Market Cap

$292.93M

Avg Vol (3M)

$293.78K

Beta

0.63

Div Yield

-

MASS Company Profile


908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Show More

Industry

Medical - Specialties

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

172

IPO Date

Dec 18, 2020

Website

MASS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Contract$117.00K$317.00K$370.00K
Device Sales$36.66M$35.99M$33.38M
Recurring$19.42M$23.32M$16.48M
Product and service revenue$6.99M$59.63M$49.86M

Fiscal year ends in Dec 25 | Currency in USD

MASS Financial Summary


Dec 25Dec 24Dec 23
Revenue$56.20M$59.63M$50.23M
Operating Income$-39.42M$-76.72M$-42.76M
Net Income$19.49M$-72.21M$-36.40M
EBITDA$-21.50M$-43.88M$-40.27M
Basic EPS$0.54$-2.12$-1.13
Diluted EPS$0.54$-2.12$-1.13

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Mar 03, 26 | 8:30 AM
Q3 25Nov 10, 25 | 8:30 AM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health Inc.
SENSSenseonics Holdings, Inc.
QTRXQuanterix Corporation
CERSCerus Corporation
SGHTSight Sciences, Inc.
ACRSAclaris Therapeutics, Inc.
NNOXNano-X Imaging Ltd.
NPCENeuroPace, Inc.
CAPRCapricor Therapeutics, Inc.
CVRXCVRx, Inc.